Viajes aéreos y patología pulmonar con riesgo de hipoxemia.

Carlos Alberto Fiore, Walter Marcelo Córsico

Resumen


Uno de los motivos de consulta cada vez más frecuente es el riesgo de volar de los pacientes con enfermedades pulmonares crónicas. La presión de la cabina no es la misma que a nivel del mar, lo que significa disminución en la fracción inspirada de O2, esto puede representar una hipoxia significante en pacientes asintomáticos en su vida diaria, para evitar riesgos es indispensable el uso de O2 suplementario durante el vuelo. Los métodos para la identificación de las personas con riesgo de hipoxemia y los cambios fisiopatológicos que ocurren en la altura para producirla son analizados.


Palabras clave


viaje aéreo; EPOC; hipoxemia; altitud; test de desafío hipóxico

Texto completo:

64-67

Referencias


http://www.aerocomercial.gov.ar/estadisticas. Página de la subsecretaria de transporte aerocomercial.

http://www.goldcopd.com/GuidelinesResources. Executive Summary: Global Strategy for the Diagnosis, management and Prevention of COPD. Revised 2007.

Cottrell JJ. Altitude exposures during aircraft flight. Flying higher. Chest 1988; 92: 81-4.

British Thoracic Society. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 2002; 57:289-304. 2004 update: http://www.brit-thoracic.org.uk

Muhm JM, Rock PB, McMullin DL, et al. Effect of Aircraft-Cabin Altitude on Passenger Discomfort. N Engl J Med 2007; 357:18-27.

Robson AG and Innes JA. Problems of air travel for patients with lung disease: clinical criteria and regulations. Breathe 2006; 3 (2): 141-7.

Schreijer AJ, Cannegieter SC, Meijers JC, et al. Activation of coagulation system during air travel: a crossover study. Lancet 2006; 367: 832-8.

Stenmark KR, Davie NJ, Reeves JT et al. Hypoxia, leukocytes and the pulmonary circulation. J Appl Physiol 2005; 98:715-721.

Bass JL, Corwin M, Gozal D, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics 2004; 114: 805-816.

ATS Statement guidelines for the six-minutes walk test. Am J Respir Crit Care Med 2002; 166:111-7.

Singh SJ, Morgan MD, Scott S et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47:1019-1024.

Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exer 1982; 14:377-381.

Gift AG. Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehab Nurs 1989; 14:313-325.

Gong H, Tashkin DP, Lee EY et al. Hypoxia-altitude simulation test. Am Rev Resp Dis 1984; 130:980-6.

Henry JN, Krenis LJ and Cutting RT. Hypoxaemia during aeromedical evacuation. Surgery, Gynecology and Obstetrics 1973; 136:49-53

Apte NM and Karnad DR. Altitude hypoxaemia and the arterial-to-alveolar oxygen ratio. Ann Int Med 1990; 112:547-548

Dillard TA, Rosenberg AP and Berg BW. Hypoxaemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease. Chest 1993; 103:422-5

Cramer D, Ward S and Geddes D. Assessment of oxygen supplementation during air travel. Thorax 1996; 51:202-3.

Robson AG, Hartung TK and Innes JA. Laboratory assessment of fitness to fly in patients with lung disease: a practical approach. Eur Respir J 2000; 16:214-9.

Berg BW, Dillard TA, Rajagopal KR et al. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. Chest 1992; 101:638-641


Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2019 Carlos Alberto Fiore, Walter Marcelo Córsico



Asociación Médica de Bahía Blanca - Castelli 213 - B8000AIE Bahía Blanca - Buenos Aires - Argentina - https://www.ambb.org.ar